NOVAVAX INC
Biological Products, (No Diagnostic Substances) · 21 FIRSTFIELD RD, GAITHERSBURG, MD
Xibaaru lim bu oficial
0ki topp
1987sosu na
Ci NOVAVAX INC
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
Source: Wikipedia
LiggéeyBiological Products, (No Diagnostic Substances)
Kër bu mag21 FIRSTFIELD RD, GAITHERSBURG, MD
Sos nañu ko1987
Melokaan yoonC Corporation
NekkinDox
Brevet18 brevet
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITYJP2025128159A · 2025
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITYJP2024038170A · 2024
Duggal ngir gis 18 patant yépp
Seet portfolio patant yépp, ak nimero publikaasiyon yi, bés yi ak njaboot yi.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Nimero yu am solo
Duggal ngir gis lim yu am solo yi
Njëg, ñoor bu set ak limu liggéeykat yu NOVAVAX INC ci at yi, ak fi ñu jële.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Xibaaru yoon
| Turu yoon | NOVAVAX INC |
|---|---|
| Melokaan yoon | C Corporation |
| SEC CIK | 1000694Xool ci SEC EDGAR ↗ |
| EIN | 22-2816046 |
| Kodu wàll (SIC) | 2836 |
| Adresu bindu | 21 FIRSTFIELD RD, GAITHERSBURG, MD |
| Nekkin | Dox |
Cosaan: SEC EDGAR · yeesal Oct. 15, 2026
Jokkoo & lëkkalekaay
Barab
21 FIRSTFIELD RD, GAITHERSBURG, MD
Ndax sa sosiete la?
Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.
Jël xët biiBokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte
Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.
Bokku léegi — amul fay